Potential blockbusters and root-cause treatments from Eli Lilly, Merck, Takeda and others could get a regulatory nod this ...

46 new molecular entities cleared the agency’s hurdles last year, 4 fewer than in 2024 ...

The U.S. Food and Drug Administration (FDA) is the primary federal agency responsible for safeguarding public health by ensuring the safety, efficacy, and security of a wide range of products, ...

Beginning in January 2026, this pill - developed by Danish pharmaceutical company Novo Nordisk - will become a daily option ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...